AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 71 filers reported holding AUTOLUS THERAPEUTICS PLC in Q3 2023. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,449 | -87.4% | 622 | -87.1% | 0.00% | – |
| Q2 2023 | $11,507 | +857.3% | 4,835 | +640.4% | 0.00% | – |
| Q1 2023 | $1,202 | +22.4% | 653 | +26.3% | 0.00% | – |
| Q4 2022 | $982 | -1.8% | 517 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | -50.0% | 517 | -17.4% | 0.00% | – |
| Q2 2022 | $2,000 | -81.8% | 626 | -76.8% | 0.00% | – |
| Q1 2022 | $11,000 | -88.0% | 2,704 | -84.7% | 0.00% | – |
| Q4 2021 | $92,000 | -1.1% | 17,696 | +24.7% | 0.00% | – |
| Q3 2021 | $93,000 | +9200.0% | 14,191 | +6593.9% | 0.00% | – |
| Q2 2021 | $1,000 | -99.3% | 212 | -99.2% | 0.00% | – |
| Q1 2021 | $152,000 | +2940.0% | 26,597 | +4615.8% | 0.00% | – |
| Q4 2020 | $5,000 | -98.5% | 564 | -98.1% | 0.00% | – |
| Q3 2020 | $337,000 | +33600.0% | 28,938 | +52514.5% | 0.00% | – |
| Q2 2020 | $1,000 | -66.7% | 55 | -88.3% | 0.00% | – |
| Q1 2020 | $3,000 | -66.7% | 470 | -30.1% | 0.00% | – |
| Q4 2019 | $9,000 | +800.0% | 672 | +460.0% | 0.00% | – |
| Q3 2019 | $1,000 | -95.8% | 120 | -92.0% | 0.00% | – |
| Q2 2019 | $24,000 | +2300.0% | 1,509 | +3110.6% | 0.00% | – |
| Q1 2019 | $1,000 | -96.8% | 47 | -95.0% | 0.00% | – |
| Q4 2018 | $31,000 | – | 948 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Syncona Portfolio Ltd | 21,346,829 | $49,738,112 | 74.10% |
| TFG Asset Management GP Ltd | 12,000,000 | $27,960,000 | 5.10% |
| Paradigm Biocapital Advisors LP | 14,406,782 | $33,567,802 | 2.28% |
| Lynx1 Capital Management LP | 1,363,025 | $3,175,848 | 2.10% |
| Deep Track Capital, LP | 15,000,000 | $34,950,000 | 1.35% |
| Affinity Asset Advisors, LLC | 1,992,466 | $4,642,446 | 1.31% |
| DAFNA Capital Management LLC | 928,253 | $2,162,829 | 0.67% |
| Frazier Life Sciences Management, L.P. | 3,746,857 | $8,730,177 | 0.58% |
| ARMISTICE CAPITAL, LLC | 6,900,000 | $16,077,000 | 0.25% |
| Blackstone Inc. | 20,485,611 | $47,731,474 | 0.20% |